Some pharmaceutical makers may be targets -Barron's

NEW YORK Sun Jan 30, 2011 1:05pm EST

NEW YORK Jan 30 (Reuters) - Major drug makers are looking for products by purchasing smaller companies, creating many value opportunities, Barron's reported in its Jan. 31 edition.

Among the companies that Barron's singled out were Acorda (ACOR.O), AMAG Pharmaceuticals (AMAG.O), Alexion (ALXN.O), BioMarin (BMRN.O), Cadence CADX.O, Cephalon CEPH.O, Cubist (CBST.O), Dendreon (DNDN.O), Human Genome HGSI.O, Jazz Pharma (JAZZ.O), Onyx ONXX.O, United Therapeutics (UTHR.O), and Salix Pharmaceuticals (SLXP.O). (Reporting by Caroline Humer; Editing by Marguerita Choy)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.